Aldeyra Therapeutics, Inc. Liabilities and Equity
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-06
- 2026-06-30: Liabilities and Equity $47.54M.
- 2026-03-31: Liabilities and Equity $66.48M.
- 2025-12-31: Liabilities and Equity $72.06M.
- 2025-09-30: Liabilities and Equity $77.80M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $47.54M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $66.48M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $72.06M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $77.80M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $84.96M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $93.20M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $104.61M 10-K · filed 2026-02-27 |
| 2024-09-30 | $117.32M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $126.04M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $141.30M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $148.33M 10-K · filed 2025-02-28 |
| 2023-09-30 | $147.28M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $155.62M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $168.22M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $181.29M 10-K · filed 2024-03-07 |
| 2022-09-30 | $189.69M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $201.02M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $222.69M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $233.14M 10-K · filed 2023-03-09 |
| 2021-09-30 | $247.22M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $256.43M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $147.31M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $83.35M 10-K · filed 2022-03-17 |
| 2020-09-30 | $88.32M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $71.63M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $63.03M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $75.52M 10-K · filed 2021-03-11 |
| 2019-09-30 | $77.44M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $73.84M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $88.13M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $95.09M 10-K · filed 2020-03-12 |
| 2018-09-30 | $37.13M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $43.29M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $40.78M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $44.17M 10-K · filed 2019-03-08 |
| 2017-09-30 | $49.23M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $26.47M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $31.53M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $25.19M 10-K · filed 2018-03-29 |
| 2016-09-30 | $29.19M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $32.88M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $23.44M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $28.20M 10-K · filed 2017-03-30 |
| 2015-09-30 | $31.35M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $33.88M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $15.93M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $8.79M 10-K · filed 2016-03-30 |
| 2014-09-30 | $10.35M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $11.81M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $2.89M 10-Q · filed 2014-06-11 |
| 2013-12-31 | $3.74M 10-K · filed 2015-03-23 |